Eva Kaergel
Impact in
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
-
- Hormonal Regulation and Hypertension
Papers in
-
- Hormonal Regulation and Hypertension 3
-
- Eicosanoids and Hypertension Pharmacology 3
- Co-authors
- Wolf‐Hagen Schunck (4 shared papers)Dominik N. Müller (3 shared papers)Horst Honeck (3 shared papers)Friedrich C. Luft (3 shared papers)Erdenechimeg Shagdarsuren (3 shared papers)Claus Scheidereit (3 shared papers)Joon-Keun Park (2 shared papers)Anette Fiebeler (2 shared papers)
- Journals
- Yeast (1 paper)Blood (1 paper)Hypertension (1 paper)Kidney International (1 paper)American Journal Of Pathology (1 paper)
- Partner nations
- GermanySwitzerlandJapan
In The Last Decade
Eva Kaergel
7 papers receiving 268 citations
Peers
Comparison fields: 5 of 52
- Biochemistry 121
- Endocrinology, Diabetes and Metabolism 79
- Cancer Research 66
- Pathology and Forensic Medicine 74
- Pharmacology 33
Countries citing papers authored by Eva Kaergel
This map shows the geographic impact of Eva Kaergel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Kaergel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Kaergel more than expected).
Fields of papers citing papers by Eva Kaergel
This network shows the impact of papers produced by Eva Kaergel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Kaergel. The network helps show where Eva Kaergel may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Kaergel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 80 | |
| 2 | 2013 | 59 | |
| 3 | 2002 | 55 | |
| 4 | 2016 | 47 | |
| 5 | 2004 | 22 | |
| 6 | 1990 | 4 | |
| 7 | I{kappa}B-{zeta} controls the constitutive NF-{kappa}B target gene network and survival of ABC DLBCL | 2013 | 4 |
About Eva Kaergel
Eva Kaergel is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 7 papers that have together received 271 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (3 papers), Hormonal Regulation and Hypertension (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), T-cell and Retrovirus Studies (2 papers), Inflammatory mediators and NSAID effects (1 paper), Renin-Angiotensin System Studies (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Alcohol Consumption and Health Effects (1 paper). The work is most often cited by research in Biochemistry (121 citations), Endocrinology, Diabetes and Metabolism (79 citations), Cancer Research (66 citations), Pathology and Forensic Medicine (74 citations) and Pharmacology (33 citations). Eva Kaergel has collaborated with scholars based in Germany, Switzerland and Japan. Frequent co-authors include Wolf‐Hagen Schunck, Dominik N. Müller, Horst Honeck, Friedrich C. Luft, Erdenechimeg Shagdarsuren, Claus Scheidereit, Joon-Keun Park, Anette Fiebeler, Michael Hummel and Hermann Haller. Their work appears in journals such as Yeast, Blood, Hypertension, Kidney International and American Journal Of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.